In the course of this investigation, the converse, siRNA- or shRNA-mediated AGR2 knockdown, was shown to inhibit colony and subcutaneous growth in esophageal and pancreatic cancer models [24,28]. This evidence concerns the gene AGR2 and pancreatic neoplasm.